Session 9: Adjuvant endocrine therapy for premenopausal women: Risk stratification, type & duration
Adjuvant endocrine therapy for premenopausal women: Risk stratification, type, & duration (Prudence Francis, Australia)Recorded Friday, March 22 at the 16th St. Gallen International Breast Cancer Conference Primary Therapy of Early Breast Cancer Vienna, Austria 20 - 23 March 2019 More info: http://oncoletter.ch
▶︎
HRT, breast cancer and the real risks of not taking hormones
▶︎
Mammaprint Blueprint, Updates from MINDACT 8.7 Year, & Applications in Neoadjuvant Therapy
▶︎
How Late is TOO Late to Start HRT for Women? New Research Study REVEALED
▶︎
Oncotype DX Breast Recurrence Score Assay after TAILORx and RxPONDER: What’s Next?
▶︎
Neoadjuvant and Adjuvant Treatment Considerations of ILC | Lobular Breast Cancer Event 2023
▶︎
Posture, Bone Density & Muscle: A Stanford Doctor Destroys Aging Myths Most People Believe
▶︎
Can you start HRT after 60? What the evidence shows
▶︎
The Body Reset: How Women Should Eat & Exercise for Health, Fat Loss, & Energy | Dr. Stacy Sims
▶︎
Big Brother's Kate Lawler Opens Up About Menopause Struggles (fear of HRT, symptoms & marriage)
▶︎
I’m a Pathologist: The "Biological Cost" of Ozempic and Mounjaro.
▶︎
Breast Cancer | Clinical Medicine
▶︎
Endocrine Treatment in Breast Cancer
▶︎
Pneumonia: Part 1 | Clinical Medicine
▶︎
Is it ever too late to start HRT?
▶︎
Breast Cancer Recurrence Prevention - An Illustrative Tutorial from Oster Oncology
▶︎
Vitamin D Expert: The Fastest Way To Dementia & The Big Lie About Sunlight!
▶︎
Estrogen's Side Effects: What to Expect on Hormone Therapy
▶︎
Breast Cancer: Ductal Carcinoma in Situ (DCIS) EXPLAINED
▶︎
The Science & Treatment of Obsessive Compulsive Disorder (OCD)
▶︎